Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 201 - 227 av 227 resultater
Tid
Selskap
Tittel
Sektor
Kategori
08 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics publie ses résultats du premier semestre 2021
20103010 Biotechnology
Other subject
07 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA réagit au communiqué de presse publié par Hybrigenics
20103010 Biotechnology
Other subject
07 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA reacts to the press release issued by Hybrigenics
20103010 Biotechnology
Other subject
30 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics annonce les résultats principaux de l'étude de Phase III évaluant son viscosupplément amélioré, le JTA-004, dans l'arthrose du genou
20103010 Biotechnology
Other subject
30 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
20103010 Biotechnology
Other subject
27 Aug 2021
21:00 CEST
BONE THERAPEUTICS
Bone Therapeutics renforce sa structure financière grâce à la mise en œuvre de son accord de financement avec la Banque Européenne d’Investissement et la réception d'une offre de déboursement concernant la première tranche de 8,0 M€
20103010 Biotechnology
Other subject
27 Aug 2021
21:00 CEST
BONE THERAPEUTICS
Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank and the reception of a disbursement offer for the first tranche of €8.0 million
20103010 Biotechnology
Other subject
06 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021
20103010 Biotechnology
General meeting / Board Meeting
06 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Convocation à l’Assemblée générale extraordinaire du 23 août 2021
20103010 Biotechnology
General meeting / Board Meeting
27 Jul 2021
19:00 CEST
BONE THERAPEUTICS
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
20103010 Biotechnology
Other subject
27 Jul 2021
19:00 CEST
BONE THERAPEUTICS
Bone Therapeutics et la FSMA s’accordent sur une décision définitive relative à la communication des études cliniques de 2016 et 2017
20103010 Biotechnology
Other subject
19 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics provides update on the progress of clinical studies
20103010 Biotechnology
Other subject
19 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics fait le point sur l’avancement de ses études cliniques
20103010 Biotechnology
Other subject
12 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer
20103010 Biotechnology
Corporate life
12 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutic nomme le Dr. Anne Leselbaum, MD, en qualité de Directrice Médicale
20103010 Biotechnology
Corporate life
05 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 5 August 2021
20103010 Biotechnology
General meeting / Board Meeting
05 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Convocation à l’Assemblée générale extraordinaire du 5 août 2021
20103010 Biotechnology
General meeting / Board Meeting
01 Jul 2021
07:00 CEST
BONE THERAPEUTICS
La Banque Européenne d’Investissement accorde un prêt de 16 M€ à Bone Therapeutics pour l’accélération du développement clinique et commercial de ses traitements orthopédiques innovants
20103010 Biotechnology
Other subject
01 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatment
20103010 Biotechnology
Other subject
30 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Publication des résultats de l’étude de phase I/IIa d’ALLOB pour le traitement des fractures à retard de consolidation dans la revue scientifique de référence Stem Cell Research & Therapy
20103010 Biotechnology
Other subject
30 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy
20103010 Biotechnology
Other subject
10 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics annonce les résultats de son Assemble Générale Annuelle
20103010 Biotechnology
General meeting / Board Meeting
10 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics announces Annual General Meeting results
20103010 Biotechnology
General meeting / Board Meeting
26 May 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics Provides First Quarter 2021 Business Update
20103010 Biotechnology
Other subject
26 May 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics fait le point sur ses activités du premier trimestre 2021
20103010 Biotechnology
Other subject
20 May 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics to participate in upcoming conferences
20103010 Biotechnology
Meetings / events
20 May 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics annonce sa participation à plusieurs conférences
20103010 Biotechnology
Meetings / events
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
3
4
5
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva